THE MODERN LIVING PEACE TRAIN™
Checking your passage…
One moment while your discovery opens.
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): essential context
Sources and review scope
These source notes explain the evidence consulted and its limits. Educational information does not replace individual medical care.
- ME-BASE
- CDC: ME/CFS basics
Key points; overview; everyday function · Exact identified sections read through the web reader on 11 November 2026 UTC; bounded source verification, not clinical appraisal.
Official educational guidance; not a trial-level comparative efficacy appraisal.
- ME-SYM
- CDC: symptoms of ME/CFS
Primary symptoms; PEM; sleep; orthostatic intolerance · Exact identified sections read through the web reader on 11 November 2026 UTC; bounded source verification, not clinical appraisal.
Official educational guidance; not a trial-level comparative efficacy appraisal.
- ME-MANAGE
- CDC: manage ME/CFS
Overview; post-exertional malaise; activity management · Exact identified sections read through the web reader on 11 November 2026 UTC; bounded source verification, not clinical appraisal.
Official educational guidance; not a trial-level comparative efficacy appraisal.
- ME-LIVE
- CDC: living with ME/CFS
How it impacts everyday life; everyday strategies · Exact identified sections read through the web reader on 11 November 2026 UTC; bounded source verification, not clinical appraisal.
Official educational guidance; not a trial-level comparative efficacy appraisal.
- ME-NHS-T
- NHS: ME/CFS treatment
Individual treatment plans; energy management; GET; CBT; diet · Exact identified sections read through the web reader on 11 November 2026 UTC; bounded source verification, not clinical appraisal.
Official educational guidance; not a trial-level comparative efficacy appraisal.
- ME-NHS
- NHS: ME/CFS overview
Symptoms; diagnosis; treatment · Exact identified sections read through the web reader on 11 November 2026 UTC; bounded source verification, not clinical appraisal.
Official educational guidance; not a trial-level comparative efficacy appraisal.